Zhang F - Search Results

1

Is the result of modified Allen's test still accurate after endoscopic thoracic sympathectomy?

Zhang J, Cheng Y, Chen D, Zhang F, Duan S, Chen L, Chen C, Sang Y, Shi L, Yang W, Chen Y. Zhang J, et al. Among authors: zhang f. J Thorac Dis. 2020 Mar;12(3):696-704. doi: 10.21037/jtd.2019.12.112. J Thorac Dis. 2020. PMID: 32274135 Free PMC article.

2

Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation.

Yang WT, Chen DL, Zhang FQ, Xia YC, Zhu RY, Zhou DS, Chen YB. Yang WT, et al. Asian Pac J Cancer Prev. 2014;15(18):7825-9. doi: 10.7314/apjcp.2014.15.18.7825. Asian Pac J Cancer Prev. 2014. PMID: 25292071 Free article.

3

[XAF1 inhibits cell proliferation and induces apoptosis in human lung adenocarcinoma cell line A549 in vitro].

Chen D, Zhang F, Sang Y, Zhu R, Zhang H, Chen Y. Chen D, et al. Among authors: zhang f, zhang h. Zhongguo Fei Ai Za Zhi. 2014 Dec;17(12):829-33. doi: 10.3779/j.issn.1009-3419.2014.12.01. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25539606 Free PMC article. Chinese.

4

JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.

Zhang FQ, Yang WT, Duan SZ, Xia YC, Zhu RY, Chen YB. Zhang FQ, et al. Oncotarget. 2015 Jun 10;6(16):14329-43. doi: 10.18632/oncotarget.3685. Oncotarget. 2015. PMID: 25869210 Free PMC article.

5

Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer.

Zhang F, Duan S, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. Zhang F, et al. Cancer Sci. 2016 Jun;107(6):746-54. doi: 10.1111/cas.12937. Epub 2016 May 3. Cancer Sci. 2016. PMID: 27009878 Free PMC article.

6

Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer.

Zhang F, Shen M, Yang L, Yang X, Tsai Y, Keng PC, Chen Y, Lee SO, Chen Y. Zhang F, et al. Cancer Biol Ther. 2017 Aug 3;18(8):606-615. doi: 10.1080/15384047.2017.1345391. Epub 2017 Jul 7. Cancer Biol Ther. 2017. PMID: 28686074 Free PMC article.

7

[Surgical Treatment of Refractory Chest Tumors Assisted  by Cardiopulmonary Bypass].

Zhu R, Duan S, Yang W, Shi L, Zhang F, Chen Y. Zhu R, et al. Among authors: zhang f. Zhongguo Fei Ai Za Zhi. 2018 Apr 20;21(4):313-317. doi: 10.3779/j.issn.1009-3419.2018.04.17. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29587914 Free PMC article. Chinese.

8

Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway.

Chen D, Zhang F, Wang J, He H, Duan S, Zhu R, Chen C, Yin L, Chen Y. Chen D, et al. Among authors: zhang f. Front Pharmacol. 2018 Nov 13;9:1214. doi: 10.3389/fphar.2018.01214. eCollection 2018. Front Pharmacol. 2018. PMID: 30483119 Free PMC article.

9

Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.

Qiu X, Chen D, Liu Y, Duan S, Zhang F, Zhang Y, Li F, Chen C, Chen Y. Qiu X, et al. Among authors: zhang f, zhang y. Thorac Cancer. 2019 Feb;10(2):256-267. doi: 10.1111/1759-7714.12945. Epub 2019 Jan 3. Thorac Cancer. 2019. PMID: 30605235 Free PMC article.

10

Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.

Wen J, Liu D, Chen D, Chen J, Xu X, Chen C, Zhang F, Duan S, Zhu R, Fan M, Chen Y. Wen J, et al. Among authors: zhang f. Biosci Rep. 2019 Feb 1;39(2):BSR20181545. doi: 10.1042/BSR20181545. Print 2019 Feb 28. Biosci Rep. 2019. PMID: 30647107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,550 results

Search Page

Filters